Literature DB >> 3436041

Enzymatic determination of bilirubin fractions in serum.

A Kosaka1, C Yamamoto, Y Morishita, K Nakane.   

Abstract

Novel enzymatic methods using bilirubin oxidase from Myrothecium verrucaria are described for the determination of bilirubin fractions in serum. These fractions include an unconjugated form (Bu), a conjugated form (Bc), and a delta fraction of bilirubin that reacts with direct diazo reagent and is irreversibly bound to serum albumin (B delta). The determination is based on the different reactivities of the enzyme to bilirubin fractions at different pH in the presence or absence of anionic detergent such as sodium dodecyl sulfate (SDS) or sodium cholate. Thus, in the absence of detergents, Bc and B delta are oxidized at acidic pH, while Bc is oxidized at alkaline pH; Bu is not oxidized at either acidic or alkaline pH. The first approach is based on measuring the decreased absorbance of bilirubin colour at 450 nm caused by the enzymatic oxidation. Total bilirubin is measured at pH 8.0 in the presence of SDS. Direct bilirubin is measured at pH 3.7 and Bc is measured at pH 10.0 in the absence of SDS, respectively. The second approach is made by coupling the diazo reaction with the enzyme reaction. Total and direct bilirubin are determined by a conventional diazo method without prior treatment by the enzyme. B delta is determined with a direct diazo method after the serum sample is treated at pH 10.0 by the enzyme to oxidize the Bc fraction. The precision and the accuracy of these methods were compared with a diazo method, an HPLC method and a slide method, and good results were obtained.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436041     DOI: 10.1016/0009-9120(87)90014-2

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Bilirubin oxidase activity of Bacillus subtilis CotA.

Authors:  Shin-ichi Sakasegawa; Hidehiko Ishikawa; Shigeyuki Imamura; Haruhiko Sakuraba; Shuichiro Goda; Toshihisa Ohshima
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Purification and properties of bilirubin oxidase from Myrothecium verrucaria.

Authors:  J Guo; X X Liang; P S Mo; G X Li
Journal:  Appl Biochem Biotechnol       Date:  1991-11       Impact factor: 2.926

3.  Conformation of bilirubin oxidase in native and denatured states.

Authors:  T Samejima; C S Wu; K Shiboya; H Kaji; S Koikeda; K Ando; J T Yang
Journal:  J Protein Chem       Date:  1994-04

4.  Enzymatic assay for conjugated bilirubin (Bc) in serum using bilirubin oxidase (BOD).

Authors:  S Kimura; S Iyama; Y Yamaguchi; S Hayashi; T Yanagihara
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

5.  Bilirubin oxidase from Bacillus pumilus: a promising enzyme for the elaboration of efficient cathodes in biofuel cells.

Authors:  Fabien Durand; Christian Hauge Kjaergaard; Emmanuel Suraniti; Sébastien Gounel; Ryan G Hadt; Edward I Solomon; Nicolas Mano
Journal:  Biosens Bioelectron       Date:  2012-02-25       Impact factor: 10.618

6.  X-ray analysis of bilirubin oxidase from Myrothecium verrucaria at 2.3 A resolution using a twinned crystal.

Authors:  Kimihiko Mizutani; Mayuko Toyoda; Kenta Sagara; Nobuyuki Takahashi; Atsuko Sato; Yuji Kamitaka; Seiya Tsujimura; Yuji Nakanishi; Toshiyuki Sugiura; Shotaro Yamaguchi; Kenji Kano; Bunzo Mikami
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-06-23

7.  Bilirubin oxidase from Magnaporthe oryzae: an attractive new enzyme for biotechnological applications.

Authors:  Fabien Durand; Sébastien Gounel; Christian H Kjaergaard; Edward I Solomon; Nicolas Mano
Journal:  Appl Microbiol Biotechnol       Date:  2012-02-15       Impact factor: 4.813

8.  Fluorescent protein-based detection of unconjugated bilirubin in newborn serum.

Authors:  Sota Iwatani; Hajime Nakamura; Daisuke Kurokawa; Keiji Yamana; Kosuke Nishida; Sachiyo Fukushima; Tsubasa Koda; Noriyuki Nishimura; Hisahide Nishio; Kazumoto Iijima; Atsushi Miyawaki; Ichiro Morioka
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.